Matt Henriksen

Okay, and that kind of gets us into more of that integrating it all into one device that we'll talk about a little bit later.

And so then you have the app as well.

One of the things too, just, you know, between...

the product development and the recent de novo approval as just the pivotal trial.

There was news about enrollment ending.

Was that data presented to the FDA before?

Is that clinical data going to be provided and published at one of these diabetes conferences in the near term?

Yeah.

And that's, I mean, the fact that you use, you know, venous draws, you use finger sticks and you use CGMs as all kind of as comparables, highlights, you know, because it's such a new technology, you want to make sure that you- The scientific rigor.

Yeah, exactly.

And so then, you know,

But going back, is that something then the public can see that data published maybe ADA next year?

I know DTM is coming up in November.

Is that something that we can all look forward to?

Okay.

Yeah.

They made it in person again for the first time in a few years, right?

But also, is that one out in California?

Yes.

California is much nicer than Bethesda in November, in my personal opinion.